• This record comes from PubMed

Benzoxazin-4-ones as novel, easily accessible inhibitors for rhomboid proteases

. 2018 May 01 ; 28 (8) : 1423-1427. [epub] 20171226

Language English Country England, Great Britain Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

Links

PubMed 29506958
DOI 10.1016/j.bmcl.2017.12.056
PII: S0960-894X(17)31230-1
Knihovny.cz E-resources

Rhomboid proteases form one of the most widespread intramembrane protease families. They have been implicated in variety of human diseases. The currently reported rhomboid inhibitors display some selectivity, but their construction involves multistep synthesis protocols. Here, we report benzoxazin-4-ones as novel inhibitors of rhomboid proteases with a covalent, but slow reversible inhibition mechanism. Benzoxazin-4-ones can be synthesized from anthranilic acid derivatives in a one-step synthesis, making them easily accessible. We demonstrate that an alkoxy substituent at the 2-position is crucial for potency and results in low micromolar inhibitors of rhomboid proteases. Hence, we expect that these compounds will allow rapid synthesis and optimization of inhibitors of rhomboids from different organisms.

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

4-Oxo-β-lactams as Covalent Inhibitors of the Mitochondrial Intramembrane Protease PARL

. 2024 Dec 12 ; 15 (12) : 2101-2106. [epub] 20241114

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...